11. 495 Basal cell carcinoma demonstrates a T-cell exclusion immune phenotype in contrast to other anti-PD-1 therapy responsive cutaneous malignancies. (9th November 2020) Authors: Gibney, Geoffrey; Xiu, Joanne; In, Gino; O'Day, Steven; Lutzky, Jose; Drabick, Joseph; VanderWalde, Ari; Poorman, Kelsey; Korn, W; Atkins, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Advances in immunotherapy for melanoma. Issue 1 (December 2016) Authors: Redman, Jason; Gibney, Geoffrey; Atkins, Michael Journal: BMC medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2). Issue 2 (December 2015) Authors: Erbe, Amy; Wang, Wei; Kim, Kyung; Carmichael, Laskeesha; Gallendberger, MIkayla; Hess, Dustin; Mendonca, Eneida; Song, Yiqiang; Hank, Jacquelyn; Chen, Su-Chun; Signoretti, Sabina; Atkins, Michael; Carlson, Alexander; Mier, James; Panka, David; McDermott, David; Sondel, Paul Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma. (19th December 2018) Authors: Tarhini, Ahmad; McDermott, David; Ambavane, Apoorva; Gupte-Singh, Komal; Aponte-Ribero, Valerie; Ritchings, Corey; Benedict, Agnes; Rao, Sumati; Regan, Meredith M; Atkins, Michael Journal: Immunotherapy Issue: Volume 11:Number 4(2019) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma. (1st February 2018) Authors: Atkins, Michael; Coutinho, Anna D.; Nunna, Sasikiran; Gupte-Singh, Komal; Eaddy, Michael Journal: Journal of medical economics Issue: Volume 21:Number 2(2018) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Experiences of individuals self-directing Medicaid Home and Community-Based Services during COVID-19. Issue 3 (July 2022) Authors: Caldwell, Joseph; Heyman, Miriam; Atkins, Michael; Ho, Sandy Journal: Disability and health journal Issue: Volume 15:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd–6th 2014. Issue 1 (December 2015) Authors: Ascierto, Paolo; Atkins, Michael; Bifulco, Carlo; Botti, Gerardo; Cochran, Alistair; Davies, Michael; Demaria, Sandra; Dummer, Reinhard; Ferrone, Soldano; Formenti, Silvia; Gajewski, Thomas; Garbe, Claus; Khleif, Samir; Kiessling, Rolf; Lo, Roger; Lorigan, Paul; Arthur, Grant; Masucci, Giuseppe; ... Journal: Journal of translational medicine Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016) Authors: Nanda, Vashisht; Peng, Weiyi; Hwu, Patrick; Davies, Michael; Ciliberto, Gennaro; Fattore, Luigi; Malpicci, Debora; Aurisicchio, Luigi; Ascierto, Paolo; Croce, Carlo; Mancini, Rita; Spranger, Stefani; Gajewski, Thomas; Wang, Yangyang; Ferrone, Soldano; Vanpouille-Box, Claire; Wennerberg, Erik; Pil... Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma. Issue 2 (December 2015) Authors: Atkins, Michael; Gupta, Shilpa; Choueiri, Toni; McDermott, David; Puzanov, Igor; Tarazi, Jamal; Keefe, Stephen; Rosbrook, Brad; Chakrabarti, Debasis; Plimack, Elizabeth Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. (December 2018) Authors: McDermott, David; Huseni, Mahrukh; Atkins, Michael; Motzer, Robert; Rini, Brian; Escudier, Bernard; Fong, Lawrence; Joseph, Richard; Pal, Sumanta; Reeves, James; Sznol, Mario; Hainsworth, John; Rathmell, W.; Stadler, Walter; Hutson, Thomas; Gore, Martin; Ravaud, Alain; Bracarda, Sergio; Suárez, C... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗